survival times; correction rates of the DNA region spanning the -124C>T mutation in the TERT promoter of the combined tumor tissues; telomere length; expression levels of TERT, Ki67 and cleaved PARP1; cell proliferation assay. This evidence concerns the gene TERT and neoplasm.